Anthera Pharmaceuticals Analysis
| ANTHDelisted Stock | USD 0.0001 0.00 0.00% |
Anthera Pharmaceuticals is overvalued with Real Value of 8.5E-5 and Hype Value of 1.0E-4. The main objective of Anthera Pharmaceuticals pink sheet analysis is to determine its intrinsic value, which is an estimate of what Anthera Pharmaceuticals is worth, separate from its market price. There are two main types of Anthera Pharmaceuticals' stock analysis: fundamental analysis and technical analysis.
The Anthera Pharmaceuticals pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Anthera Pharmaceuticals' ongoing operational relationships across important fundamental and technical indicators.
Anthera |
Anthera Pink Sheet Analysis Notes
The company has price-to-book (P/B) ratio of 0.11. Some equities with similar Price to Book (P/B) outperform the market in the long run. Anthera Pharmaceuticals recorded a loss per share of 1.76. The entity last dividend was issued on the 1st of May 2017. The firm had 1:8 split on the 1st of May 2017. Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. Anthera Pharmaceuticals, Inc. was founded in 2004 and is based in Houston, Texas. Anthera Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 21 people.The quote for Anthera Pharmaceuticals is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Anthera Pharmaceuticals please contact John Thompson at 410 350 1839 or go to https://www.anthera.com.Anthera Pharmaceuticals Investment Alerts
| Anthera Pharmaceuticals is not yet fully synchronised with the market data | |
| Anthera Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Anthera Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (26.87 M) with loss before overhead, payroll, taxes, and interest of (28.49 M). | |
| Anthera Pharmaceuticals currently holds about 8.09 M in cash with (36.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.31, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Anthera Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 617.83 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Anthera Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Anthera Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Anthera Pharmaceuticals Outstanding Bonds
Anthera Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Anthera Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Anthera bonds can be classified according to their maturity, which is the date when Anthera Pharmaceuticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| US03674XAS53 Corp BondUS03674XAS53 | View | |
| US03674XAQ97 Corp BondUS03674XAQ97 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View |
About Anthera Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Anthera Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Anthera shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Anthera Pharmaceuticals. By using and applying Anthera Pink Sheet analysis, traders can create a robust methodology for identifying Anthera entry and exit points for their positions.
Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. Anthera Pharmaceuticals, Inc. was founded in 2004 and is based in Houston, Texas. Anthera Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 21 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Anthera Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in Anthera Pink Sheet
If you are still planning to invest in Anthera Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Anthera Pharmaceuticals' history and understand the potential risks before investing.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |